OL Oncology Letters 1792-1074 1792-1082 D.A. Spandidos 10.3892/ol.2025.15318 OL-30-6-15318 Retraction [Retracted] Effect of interventional embolotherapy on FHIT and p16 expression in hepatocellular carcinoma patients XuWei QiXiaogai WangXia SunJize 122025 06102025 30 6 572 Copyright: © 2025 Xu et al. 2025 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.

Oncol Lett 17: 871–876, 2019; DOI: 10.3892/ol.2018.9648

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the control western blot data shown in Fig. 3 on p. 874 were strikingly similar to data that were already under consideration for publication in another article written by different authors at different research institutes. Owing to the fact that the contentious data in the above article had already been submitted for publication prior to its submission to Oncology Letters, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.